Venous thromboembolism (VTE) is the third most common life-threatening cardiovascular
condition in the United States, with African Americans (AAs) having a 30% to 60% higher …

Venous thromboembolism (VTE) is a significant contributor to morbidity and mortality. To
advance our understanding of the biology contributing to VTE, we conducted a genome …

Background: Venous thromboembolism (VTE) is a life-threatening vascular event with
environmental and genetic determinants. Recent VTE genome-wide association studies …

To identify novel single nucleotide polymorphisms (SNPs) associated with venous
thromboembolism (VTE) in African-Americans (AAs), we performed a genome-wide …

Objectives: To identify venous thromboembolism (VTE) disease‐susceptibility genes.
Patients and methods: We performed in silico genome wide association scan (GWAS) …

Essentials Genetic architecture of venous thromboembolism (VTE) remains to be fully
disentangled. 11 newly discovered candidate polymorphisms were genotyped in 3019 VTE …

Venous thromboembolism (VTE), the third leading cause of cardiovascular mortality, is a
complex thrombotic disorder with environmental and genetic determinants. Although several …

Previous genome-wide association studies (GWASs) have established several susceptibility
genes for venous thromboembolism (VTE) and suggested many others. However, a large …

Venous thromboembolism (VTE) is a common, heritable disease resulting in high rates of
hospitalization and mortality. Yet few associations between VTE and genetic variants, all in …

Abstract Although recent Genome‐Wide Association Studies have identified novel
associations for common variants, there has been no comprehensive exome‐wide search …